BIO (BioProtocol) fluctuates 41.0% in 24 hours: Driven by PEPTAIIgnitionSale oversubscription and trading volume surge
Bitget Pulse2026/05/02 13:35Volatility Brief
In the past 24 hours, BIO price rebounded from a low of $0.03964 to a high of $0.05590, currently trading at $0.05561, with an overall price swing of 41.0%. Trading volume has surged significantly, with a 24-hour turnover exceeding $45 million, at times reaching 25 times the average level; Open Interest (OI) has spiked 43.8%, and the funding rate has turned negative to -0.023%, indicating increasing pressure on shorts.
Brief Analysis of the Move
• Bio Protocol officially launched the PEPTAI Ignition Sale (AI agent project for peptide drugs), exceeding 5.9 times the subscription in just 30 minutes after going live, 20% of the supply was allocated to BIO stakers, incentivizing staking and USDC participation, thus driving active trading.
• Trading volume soared 207%, led by buying momentum (196K USDT within 15 minutes), with open interest rising in tandem. The negative funding rate intensified the short squeeze, resulting in a rapid price surge.
• The DeSci sector rotation has accelerated, while market attention grew due to the upgrade of BioXP and listing rumors on Upbit Korea, pushing turnover up to the $300 million level.
Market View and Outlook
The prevailing community sentiment is bullish, with long positions dominating on X, viewing the current situation as an opportunity for DeSci+AI biotech sector rotation. The target price is $0.048-$0.055, but the risk of a short-term squeeze is high (RSI at 78, indicating overbought conditions); analysts advise caution regarding a potential pullback to the $0.032-$0.037 support zone, and recommend monitoring the progress of the PEPTAI sale and staking data. If the price holds above $0.041, it is advised to maintain long positions.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for information purposes only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
When France and Germany pay for their deficits, fiscal discipline becomes the "moat" of the UK bond market; investors are positioning in advance for a rebound in gilt bonds.
Investors are betting that the new UK Chancellor, Healey, will uphold fiscal discipline and are purchasing gilts in advance. A smooth and steady budget plan is expected to turn the UK from a "risk" in the bond market into a "positive."
Anthropic's $2 Trillion IPO Faces Doubts: Risks of Mismatched Computing Commitments and Revenue
The independent institution New Constructs reported that the Anthropic IPO is absurd, with a valuation of only 150 billion. The main controversy lies in the mismatch between long-term computing power commitments and clients' short-term on-demand procurement models, coupled with macroeconomic headwinds and early investor sell-off pressure, leading to increased market volatility.
Anthropic allocates 5% of shares to set up a fund before IPO, Musk calls for direct distribution to the public
Anthropic announced the establishment of a public welfare fund, initially allocating 5% of its shares. When the company's valuation increases by 50%, another 2% will be added. The aim is to address the impact of AI on employment. Musk suggested directly distributing shares to the public.
AI Stocks Struggle to Rebound: Lacking Three Major Supports, July’s Rally Hard to Replicate
JPMorgan pointed out that due to the absence of ETF bargain-hunting funds, limited room for short covering, and the early termination of the $40 billion buyback by Samsung and SK Hynix, the rebound strength of AI stocks in October may not match that of July. The resurgence of leverage risk could intensify volatility.
Crypto prices
More
